Your browser doesn't support javascript.
loading
Synergistic activity of imatinib and AR-42 against chronic myeloid leukemia cells mainly through HDAC1 inhibition.
Wei, Danna; Lu, Tingting; Ma, Dan; Yu, Kunlin; Zhang, Tianzhuo; Xiong, Jie; Wang, Weili; Zhang, Zhaoyuan; Fang, Qin; Wang, Jishi.
Afiliação
  • Wei D; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China; Department of Cl
  • Lu T; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China; Department of Cl
  • Ma D; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China.
  • Yu K; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China; Department of Cl
  • Zhang T; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China; Department of Cl
  • Xiong J; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China.
  • Wang W; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China; Department of Cl
  • Zhang Z; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China; Department of Cl
  • Fang Q; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Pharmacy, Affiliated Baiyun Hospital of Guizhou Medical University, Guiyang 550058, PR China.
  • Wang J; Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, PR China; Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre, Guiyang 550004, PR China; Department of Cl
Life Sci ; 211: 224-237, 2018 Oct 15.
Article em En | MEDLINE | ID: mdl-30248347
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilbutiratos / Leucemia Mielogênica Crônica BCR-ABL Positiva / Regulação Enzimológica da Expressão Gênica / Apoptose / Sinergismo Farmacológico / Histona Desacetilase 1 / Mesilato de Imatinib Limite: Humans Idioma: En Revista: Life Sci Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilbutiratos / Leucemia Mielogênica Crônica BCR-ABL Positiva / Regulação Enzimológica da Expressão Gênica / Apoptose / Sinergismo Farmacológico / Histona Desacetilase 1 / Mesilato de Imatinib Limite: Humans Idioma: En Revista: Life Sci Ano de publicação: 2018 Tipo de documento: Article